Department of Clinical Research, ScientificWriting Corporation, Houston, TexasUSA.
Department of Ophthalmology, Tabriz University of Medical Sciences, Tabriz, Iran.
Prehosp Disaster Med. 2020 Dec;35(6):688-689. doi: 10.1017/S1049023X20001223. Epub 2020 Sep 22.
Since the beginning of the coronavirus infectious disease 2019 (COVID-19) pandemic, an exponentially large amount of data has been published to describe the pathology, clinical presentations, and outcomes in patients infected with the severe acute respiratory syndrome novel coronavirus 2 (SARS-CoV-2). Although COVID-19 has been shown to cause a systemic inflammation predisposing the involvement of multiple organs, its mechanism affecting the urogenital system has not been well-documented. This case report presents the clinical course of two male patients with COVID-19 who developed sexual dysfunction, as anorgasmia, following recovery from the infection. Although no evidence of viral replication or inflammatory involvement could be identified in these cases' urogenital organs, a lack of other known risk factors for anorgasmia points to the role of COVID-19 as the contributing factor.
自 2019 年冠状病毒病(COVID-19)大流行开始以来,已经发表了大量数据来描述感染严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的患者的病理学、临床表现和结局。尽管 COVID-19 已被证明会引起全身性炎症,从而使多个器官受累,但它影响泌尿生殖系统的机制尚未得到充分记录。本病例报告介绍了两名男性 COVID-19 患者的临床病程,他们在感染康复后出现性功能障碍,表现为性高潮障碍。尽管在这些患者的泌尿生殖器官中未发现病毒复制或炎症受累的证据,但缺乏其他已知的性高潮障碍的危险因素提示 COVID-19 是致病因素。